Nigel Theobald
Fondateur chez N4 PHARMA PLC
Fortune : 135 171 $ au 31/05/2024
Profil
Nigel James Theobald is the founder of Abaco Capital Plc (founded in 2009), N4 Pharma Ltd.
(founded in 2014), and N4 Pharma Plc (founded in 2014).
At N4 Pharma Ltd., he held the title of Chief Executive Officer, and at N4 Pharma Plc, he held the title of Chief Executive Officer & Executive Director.
Mr. Theobald's former jobs include Non-Executive Director at Medherant Ltd.
and Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald received an undergraduate degree from The University of Southampton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
N4 PHARMA PLC
6,32% | 13/06/2024 | 16 981 319 ( 6,32% ) | 135 171 $ | 31/05/2024 |
Postes actifs de Nigel Theobald
| Sociétés | Poste | Début |
|---|---|---|
| N4 PHARMA PLC | Fondateur | 01/01/2014 |
Anciens postes connus de Nigel Theobald
| Sociétés | Poste | Fin |
|---|---|---|
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Corporate Officer/Principal | - |
N4 Pharma Ltd.
 N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Directeur Général | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Directeur/Membre du Conseil | - |
| ABACO CAPITAL PLC | Fondateur | - |
Formation de Nigel Theobald
| The University of Southampton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| N4 PHARMA PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Health Technology |
Abaco Capital Plc
 Abaco Capital Plc Financial ConglomeratesFinance Abaco Capital Plc was a drug development company, which was engaged in re-developing approved drugs using proprietary formulation technologies. The company was founded by Marcelo Bravo and Nigel Theobald on October 7, 2009 and was headquartered in London, the United Kingdom. | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Health Technology |
